A new article on G2 Intelligence outlined the effect that the Supreme Court’s ruling on the Patient Protection and Affordable Care Act will have on labs.
The new program diverges somewhat from the more commonly explored Plavix pharmacogenomics strategy of administering to patients a single CYP2C19 genotyping test to identify responders.
New research has pinpointed four genes linked to prostate cancer, which could significantly improve diagnosis and treatment of this cancer.
Tens of millions of people are expected to gain insurance from the law.
Group says improved regulatory process for personalized medicine products could foster innovation.
The legislation will reauthorize the FDA’s medical device user fee program, allowing the agency to collect an additional $308 million over 5 years to fund its regulatory activities and to take steps to modernize its review and approval processes.
Roche has launched the cobas p 312 pre-analytical system, a front-end automation solution that offers comprehensive, vendor-neutral sample management for labs with limited floor space.
Increased public awareness and advancements in medicine over the past three decades have led to remarkable strides in preventing the spread of HIV and improving the quality of life of those living with HIV or AIDS in the US.
International travelers to and from the United States who are not vaccinated and infected can expose others to measles.
Thermal Gradient Inc, a developer of disposable DNA testing devices, has initiated the manufacture of its next generation device.